Danish biotech company receives Michael J. Fox grant  

2004.07.07
The Danish biotech company NsGene, a spin-off from NeuroSearch, has received a grant of USD 3 mill (approx. DKK 18 mill.) for developing a treatment for Parkinson's disease.

The Danish biotech company NsGene, a spin-off from NeuroSearch, has received a grant of USD 3 mill (approx. DKK 18 mill.) for developing a treatment for Parkinson's disease.
The grant is awarded by the foundation of the American actor Michael J. Fox.

NsGene, who develops cell and gene based products, will use the grant for carrying out a clinical study over two years with its ECT biodelivery technology applied for Parkinson's disease.


NsGene supplements NeuroSearch's research within diseases within the central nervous system - focusing on Alzheimer's and Parkinson's disease.

NeuroSearch owns 30,9 % of NsGene; other investors include Dansk Kapitalanlæg, Karolinska Investment Fund and Lønmodtagernes Dyrtidsfond.


The news was reported at www.borsen.dk

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×